153 related articles for article (PubMed ID: 26516577)
1. Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies.
Ramachandran SD; Vivarès A; Klieber S; Hewitt NJ; Muenst B; Heinz S; Walles H; Braspenning J
Pharmacol Res Perspect; 2015 Oct; 3(5):e00161. PubMed ID: 26516577
[TBL] [Abstract][Full Text] [Related]
2. Generation of proliferating human hepatocytes using Upcyte® technology: characterisation and applications in induction and cytotoxicity assays.
Burkard A; Dähn C; Heinz S; Zutavern A; Sonntag-Buck V; Maltman D; Przyborski S; Hewitt NJ; Braspenning J
Xenobiotica; 2012 Oct; 42(10):939-56. PubMed ID: 22524704
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
[TBL] [Abstract][Full Text] [Related]
4. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
[TBL] [Abstract][Full Text] [Related]
5. Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies.
Kenny JR; Chen L; McGinnity DF; Grime K; Shakesheff KM; Thomson B; Riley R
Xenobiotica; 2008 Dec; 38(12):1500-17. PubMed ID: 18989830
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach.
Zuo R; Li F; Parikh S; Cao L; Cooper KL; Hong Y; Liu J; Faris RA; Li D; Wang H
Drug Metab Dispos; 2017 Feb; 45(2):198-207. PubMed ID: 28062541
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes.
Sahi J; Shord SS; Lindley C; Ferguson S; LeCluyse EL
J Biochem Mol Toxicol; 2009; 23(1):43-58. PubMed ID: 19202563
[TBL] [Abstract][Full Text] [Related]
8. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes by Prolyl Hydroxylase Domain 2 Inhibitors via Hypoxia-Inducible Factor-
Takano H; Yamaguchi JI; Kato S; Hamada M; Tada M; Endo H
Drug Metab Dispos; 2021 Jan; 49(1):20-30. PubMed ID: 33087449
[TBL] [Abstract][Full Text] [Related]
10. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
Schulz C; Kammerer S; Küpper JH
Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 309 molecules as inducers of CYP3A4, CYP2B6, CYP1A2, OATP1B1, OCT1, MDR1, MRP2, MRP3 and BCRP in cryopreserved human hepatocytes in sandwich culture.
Badolo L; Jensen B; Säll C; Norinder U; Kallunki P; Montanari D
Xenobiotica; 2015 Feb; 45(2):177-87. PubMed ID: 25183402
[TBL] [Abstract][Full Text] [Related]
12. HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics.
Choi JM; Oh SJ; Lee SY; Im JH; Oh JM; Ryu CS; Kwak HC; Lee JY; Kang KW; Kim SK
Arch Pharm Res; 2015; 38(5):691-704. PubMed ID: 25336106
[TBL] [Abstract][Full Text] [Related]
13. Selective Suppression of CYP3A4 mRNA and Enzyme Activity by Epidermal Growth Factor in Plated Human Hepatocytes.
Zhang JG; Wang D; Ho T; Clark RJ; Stresser DM
Drug Metab Lett; 2017; 11(2):119-127. PubMed ID: 29189189
[TBL] [Abstract][Full Text] [Related]
14. Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes.
Hendriks DFG; Vorrink SU; Smutny T; Sim SC; Nordling Å; Ullah S; Kumondai M; Jones BC; Johansson I; Andersson TB; Lauschke VM; Ingelman-Sundberg M
Clin Pharmacol Ther; 2020 Oct; 108(4):844-855. PubMed ID: 32320483
[TBL] [Abstract][Full Text] [Related]
15. An 'all-inclusive' 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes.
Halladay JS; Wong S; Khojasteh SC; Grepper S
J Pharmacol Toxicol Methods; 2012; 66(3):270-5. PubMed ID: 22809809
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction.
Hariparsad N; Carr BA; Evers R; Chu X
Drug Metab Dispos; 2008 Jun; 36(6):1046-55. PubMed ID: 18332078
[TBL] [Abstract][Full Text] [Related]
17. Generation & characterization of expandable human liver sinusoidal endothelial cells and their application to assess hepatotoxicity in an advanced in vitro liver model.
Kaden T; Noerenberg A; Boldt J; Sagawe C; Johannssen T; Rennert K; Raasch M; Evenburg T
Toxicology; 2023 Jan; 483():153374. PubMed ID: 36396002
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
Robertson P; DeCory HH; Madan A; Parkinson A
Drug Metab Dispos; 2000 Jun; 28(6):664-71. PubMed ID: 10820139
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human cytochrome P450 induction by pesticides.
Abass K; Lämsä V; Reponen P; Küblbeck J; Honkakoski P; Mattila S; Pelkonen O; Hakkola J
Toxicology; 2012 Mar; 294(1):17-26. PubMed ID: 22310298
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
